SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-007033
Filing Date
2023-03-09
Accepted
2023-03-09 16:14:40
Documents
91
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K algs-20221231.htm   iXBRL 10-K 3864757
2 EX-21.1 algs-ex21_1.htm EX-21 9699
3 EX-23.1 algs-ex23_1.htm EX-23 9065
4 EX-31.1 algs-ex31_1.htm EX-31 21772
5 EX-31.2 algs-ex31_2.htm EX-31 20096
6 EX-32.1 algs-ex32_1.htm EX-32 14869
7 EX-32.2 algs-ex32_2.htm EX-32 15610
8 GRAPHIC img15747315_0.jpg GRAPHIC 235932
9 GRAPHIC img15747315_1.jpg GRAPHIC 32644
10 GRAPHIC img15747315_2.jpg GRAPHIC 235932
11 GRAPHIC img15747315_3.jpg GRAPHIC 23635
12 GRAPHIC img15747315_4.jpg GRAPHIC 39385
13 GRAPHIC img15747315_5.jpg GRAPHIC 96564
14 GRAPHIC img15747315_6.jpg GRAPHIC 105581
15 GRAPHIC img15747315_7.jpg GRAPHIC 86374
  Complete submission text file 0000950170-23-007033.txt   15094231

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT algs-20221231.xsd EX-101.SCH 68725
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT algs-20221231_def.xml EX-101.DEF 272254
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT algs-20221231_lab.xml EX-101.LAB 623377
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT algs-20221231_cal.xml EX-101.CAL 69616
20 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT algs-20221231_pre.xml EX-101.PRE 437234
85 EXTRACTED XBRL INSTANCE DOCUMENT algs-20221231_htm.xml XML 2554528
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39617 | Film No.: 23719911
SIC: 2836 Biological Products, (No Diagnostic Substances)